Search results

...ino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB| title=Prediction of coronary heart disease using risk factor categories. | journal=Circulation | year= 1998 | volume=

{{r|Coronary heart disease}}

* "Reduce the death rate from coronary heart disease and stroke by 25 percent."

{{r|Coronary heart disease}}

{{r|Coronary heart disease}}

...ate reductase is associated with elevated levels of [[homocysteine]] and [[coronary heart disease]].<ref name="pmid17124224">{{cite journal |author=Wald DS, Wald NJ, Morris

Angina may be a symptom of [[coronary heart disease]]. The probability of underlying coronary heart disease can then be estimated (see [http://www.acc.org/qualityandscience/clinical/g

{{r|Coronary heart disease}}

{{r|Coronary heart disease}}

{{r|coronary heart disease}}

...oor fetal growth and small size at birth are followed by increased risk of coronary heart disease, stroke, hypertension, Type 2 diabetes and osteoporosis. This has led to th

{{r|Coronary heart disease}}

{{r|Coronary heart disease}}

{{r|Coronary heart disease}}

* [[Coronary heart disease]]

{{r|Coronary heart disease}}

{{r|Coronary heart disease}}

{{r|Coronary heart disease}}

{{r|Coronary heart disease}}

{{r|Coronary heart disease}}

{{r|Coronary heart disease}}

Angioplasty may be used to treat [[coronary heart disease]], [[renal artery stenosis]], and [[carotid stenosis]]. Angioplasty of the ...y is less effective than surgery for [[myocardial revascularization]] of [[coronary heart disease]]<ref name="pmid-17938385">{{cite journal |author=Bravata DM, Gienger AL, M

...[[antihypertensive agent]]s; however patients were included if they had [[coronary heart disease]] and benefit was confined to patients with prior [[myocardial infarction]]

...artery bypass]] grafting(CABG) which is a "surgical therapy of ischemic [[Coronary heart disease|coronary artery disease]] achieved by grafting a section of [[saphenous vei ...nary artery bypass is more effective for myocardial revascularization of [[coronary heart disease]] than [[percutaneous transluminal coronary angioplasty]]<ref name="pmid-17

It is unclear if measuring LDL lipoprotein subfractions improves predicting [[coronary heart disease]]. <ref name="pmid19349632">{{cite journal| author=Ip S, Lichtenstein AH, C

===Chronic stable coronary heart disease=== ...ly sensitive assay can detect elevations in patients with chronic stable [[coronary heart disease]].<ref name="pmid19940289">{{cite journal| author=Omland T, de Lemos JA, Sa

===Coronary heart disease=== ...graphy) uses multidetector [[spiral computed tomography]] for diagnosing [[coronary heart disease]].<ref name="pmid18691486">{{cite journal |author=Stein PD, Yaekoub AY, Mat

...inson JG, Rosal MC et al.| title=Optimism, cynical hostility, and incident coronary heart disease and mortality in the Women's Health Initiative. | journal=Circulation | yea

...s-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E| title=Selenium and coronary heart disease: a meta-analysis. | journal=Am J Clin Nutr | year= 2006 | volume= 84 | issu

...s/issues/v103n4/pdf/n1030593.pdf |issn=}}</ref> The strongest predictor of coronary heart disease was the presence of [[diabetes mellitus]]. The presence of bilateral caroti

...wishin KD, Eiriksdottir G, Gudnason V, Danesh J |title=Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-an

...form of [[myocardial revascularization]] that is a "surgical therapy of [[coronary heart disease|ischemic coronary artery disease]] achieved by grafting a section of saphen ...artery bypass is more effective for [[myocardial revascularization]] of [[coronary heart disease]] than [[percutaneous transluminal coronary angioplasty]]<ref name="pmid-17

...K, Prerost MR, Hughes J, Whelton PK |title=Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies |journal=N. Engl. J. Med. |volume

...a deficiency of [[cystathionine beta-synthase]] and is a risk factor for [[coronary heart disease|coronary vascular disease]]."<ref>{{MeSH|Hyperhomocysteinemia}}</ref><ref n ...have a 20% increase in serum homocysteine levels and may have increased [[coronary heart disease]].<ref name="pmid17124224"/><ref name="pmid12446535"/><ref name="OMIM - MTH

[[Hypercholesterolemia]] may contribute to [[coronary heart disease]], [[stroke]], and other complications.

...7 years of treatment with [[statin]]s, the [[relative risk reduction]] of coronary heart disease events is decreased by approximately 30%<ref name="pmid11306236">{{cite jou

...le=Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HE

* At least 3 risk factors for coronary artery disease (family history or [[coronary heart disease]], [[hypertension]], [[hypercholesterolemia]], [[diabetes]], current smokin

...r=Osganian SK, Stampfer MJ, Rimm E, ''et al'' |title=Vitamin C and risk of coronary heart disease in women |journal=J. Am. Coll. Cardiol. |volume=42 |issue=2 |pages=246–52

...y embolism]], [[computed tomographic cardiac angiography]] for detecting [[coronary heart disease]]<ref name="pmid18691486">{{cite journal |author=Stein PD, Yaekoub AY, Matt

...50 mmol/day] is projected to reduce the annual number of new cases of CHD [coronary heart disease] by 60,000 to 120,000, stroke by 32,000 to 66,000, and myocardial infarctio

...nhibitor]]. It is used in the [[secondary prevention]] of [[stroke]] and [[coronary heart disease]]. Inadequate effect in patients with [[coronary heart disease]] can be due to CYP2C19 loss-of-function alleles which are associated with

...le=Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HE

...M et al.| title=Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. | journal=N Engl J Med | year= 2010 | volume= | issue= | pages= | pmid=

...Study (UKPDS) Group| title=The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). | journal=Clin Sci (Lond) | year= 2001 | vo

...cgi/content/abstract/302/1/37 }}</ref>, its presence may help prediction [[coronary heart disease]]. ...found that the ability of the CRP to add to other methods of predicting [[coronary heart disease]] such as the [http://hp2010.nhlbihin.net/atpiii/calculator.asp Framingham

...14:45, 25 October 2011 (UTC)'Obesity is a well-established risk factor for coronary heart disease (CHD), but whether regional fat distribution contributes independently to r

...y embolism]], [[computed tomographic cardiac angiography]] for detecting [[coronary heart disease]]<ref name="pmid18691486">{{cite journal |author=Stein PD, Yaekoub AY, Matt

====Coronary heart disease and mortality==== The benefit of fish oil on [[coronary heart disease]] and mortality is controversial with conflicting conclusions reached by a

...not clear whether all of the included trials allowed patients with active coronary heart disease who would have most benefitted from a [[adrenergic beta-antagonist]].<ref n ...[[antihypertensive agent]]s; however patients were included if they had [[coronary heart disease]] and benefit was confined to patients with prior [[myocardial infarction]]